跳转至内容
Merck
CN

RV1MAG-26K

MILLIPLEX® Rat Vascular Injury Panel

Configurable Rat Vascular Injury 9-Plex Panel 1

别名:

Luminex® Rat Vascular Injury Panel, Millipore Rat Vascualr Injury Panel, Rat Vascular Injury Multiplex Assay

登录 查看组织和合同定价。

关于此项目

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MILLIPLEX® Rat Vascular Injury Panel, Configurable Rat Vascular Injury 9-Plex Panel 1

packaging

1 ea of

assay range

accuracy: 97-108%
intra-assay cv: <10%
standard curve range: 0.1-100 ng/mL
(CINC-1/GRO/KC, IL-6, MCP-1, PAI-1 (total))

standard curve range: 0.1-15 ng/mL
(VEGF)

standard curve range: 0.1-20 ng/mL
(TNFα)

standard curve range: 0.2-150 ng/mL
(TIMP-1)

standard curve range: 0.3-200 ng/mL
(CTGF)

standard curve range: 1.4-1,000 ng/mL
(Caveolin-1)

inter-assay cv: <10%
(All other analytes)

inter-assay cv: <15%
(CINC-1/GRO/KC, PAI-1 (total), TIMP-1, TNFα)

inter-assay cv: <20%
(Caveolin-1)

technique(s)

multiplexing: suitable

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

species reactivity

rat

manufacturer/tradename

Milliplex®

Quality Level

Other Notes

Sensitivity: See kit protocol for individual analytes sensitivities.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 9 analytes in rat serum or plasma samples.

Analytes included: Caveolin-1, CTGF, KC/GRO (CXCL1), IL-6, MCP-1 (CCL2), PAI-1 (Total), TIMP-1, TNFα, VEGF

Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

Features:

  • Targets a broad panel of biomarkers involved in vascular injury, inflammation, and tissue remodeling
  • Includes 9 analytes covering endothelial function, chemokine signaling, cytokine activity, and angiogenesis
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with rat serum, plasma, and tissue culture supernatant samples
  • Designed for vascular injury, fibrosis, inflammation, and regenerative research
Benefits:

  • Provides a detailed molecular profile of vascular damage and repair mechanisms
  • Supports evaluation of therapeutic interventions targeting vascular inflammation and remodeling
  • Facilitates monitoring of angiogenic and fibrotic responses in preclinical rat models
  • Enhances understanding of immune cell recruitment and cytokine signaling in vascular pathology
  • Streamlines experimental workflows with high-throughput, multi-analyte capability

General description

Biomarkers such as Caveolin-1, CTGF, KC/GRO (CXCL1), IL-6, MCP-1 (CCL2), PAI-1 (Total), TIMP-1, TNFα, and VEGF are central to understanding vascular injury, inflammation, and tissue remodeling in rat models. Caveolin-1 regulates endothelial function and vascular permeability, while CTGF is involved in fibrosis and extracellular matrix production. KC/GRO and MCP-1 are chemokines that mediate immune cell recruitment. IL-6 and TNFα are pro-inflammatory cytokines linked to vascular inflammation. PAI-1 and TIMP-1 regulate fibrinolysis and matrix turnover, and VEGF promotes angiogenesis. Together, these analytes provide a comprehensive profile of vascular damage, repair, and inflammatory signaling

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Philipp Baumann et al.
Physiological reports, 6(2) (2018-01-31)
Mechanical ventilation (MV) is routinely used in pediatric general anesthesia and critical care, but may adversely affect the cardiocirculatory system. Biomarkers are increasingly measured to assess cardiovascular status and improve clinical treatment decision-making. As the impact of mechanical ventilation strategies
Philipp Baumann et al.
American journal of translational research, 14(1), 343-354 (2022-02-18)
Intensive care practice calls for ventilator adjustments due to fast-changing clinical conditions in ventilated critically ill children. These adaptations include positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO2), and respiratory rate (RR). It is unclear which alterations in ventilator
Evandro M Neto-Neves et al.
The American journal of pathology, 187(4), 700-712 (2017-02-12)
Our understanding of the pathophysiological basis of chronic thromboembolic pulmonary hypertension (CTEPH) will be accelerated by an animal model that replicates the phenotype of human CTEPH. Sprague-Dawley rats were administered a combination of a single dose each of plastic microspheres
Mary F Barbe et al.
Journal of musculoskeletal & neuronal interactions, 19(4), 396-411 (2019-12-04)
Fibrosis is one contributing factor in motor dysfunction and discomfort in patients with overuse musculoskeletal disorders. We pharmacologically targeted the primary receptor for Substance P, neurokinin-1, using a specific antagonist (NK1RA) in a rat model of overuse with the goal
Fabrice Antigny et al.
Circulation, 133(14), 1371-1385 (2016-02-26)
Mutations in the KCNK3 gene have been identified in some patients suffering from heritable pulmonary arterial hypertension (PAH). KCNK3 encodes an outward rectifier K(+) channel, and each identified mutation leads to a loss of function. However, the pathophysiological role of

相关内容

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

了解在实验室、伴生和农业动物研究中使用生物标志物多重免疫检测产品的优势,探索MILLIPLEX®多重检测试剂盒在兽医学和动物健康研究方面的应用。

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持